WO2026033371 - ATOSIBAN COMPOSITIONS AND USES THEREOF

National phase entry is expected:
Publication Number WO/2026/033371
Publication Date 12.02.2026
International Application No. PCT/IB2025/057904
International Filing Date 04.08.2025
Title **
[English] ATOSIBAN COMPOSITIONS AND USES THEREOF
[French] COMPOSITIONS D’ATOSIBAN ET LEURS UTILISATIONS
Applicants **
FERRING B.V.
Inventors
DU, Hongliang
YU, Weiling
SUN, Pengfei
YANG, Lin
Priority Data
202411062591.5   05.08.2024   CN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2974
EPO Filing, Examination, Granting24117
Japan Filing, Examination, Granting3112
South Korea Filing, Examination, Granting4021
USA Filing, Examination, Granting12340
MasterCard Visa
Total: 46,564
Contact Us
Abstract[English] Described herein are injectable, oil-based atosiban pharmaceutical compositions and therapeutic methods using them.[French] L'invention concerne des compositions pharmaceutiques d’atosiban à base d'huile injectables et des procédés thérapeutiques les utilisant.